Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
1985-1-31
pubmed:abstractText
The capability of the Abbott Avantage system to identify 10 species of commonly isolated glucose nonfermentative or oxidase-positive gram-negative bacilli in a 5-h test period was evaluated in a collaborative study. The Avantage nonenteric data base uses 20 biochemical test reactions performed in an expanded Abbott bacterial identification cartridge plus the results of a manual oxidase test. The species included in the Avantage data base are Acinetobacter anitratus, Acinetobacter Iwoffi, Aeromonas hydrophila, Flavobacterium meningosepticum-IIb group, Pseudomonas aeruginosa, Pseudomonas cepacia, Pseudomonas fluorescens-putida group, Pseudomonas maltophilia, Pasteurella multocida, and Plesiomonas shigelloides. The collaborative study included the testing of 200 coded challenge strains in all three laboratories and the subsequent testing of an additional group of 100 to 200 clinical isolates recovered independently by each laboratory. Reference identifications for all isolates were determined by conventional biochemical test reactions. The overall accuracy of identification of the coded challenge strains for the three laboratories was 97%, whereas 95% of 437 clinical isolates and selected stock cultures of clinical derivation were identified correctly.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/6392323-323280, http://linkedlifedata.com/resource/pubmed/commentcorrection/6392323-353066, http://linkedlifedata.com/resource/pubmed/commentcorrection/6392323-353067, http://linkedlifedata.com/resource/pubmed/commentcorrection/6392323-372226, http://linkedlifedata.com/resource/pubmed/commentcorrection/6392323-379041, http://linkedlifedata.com/resource/pubmed/commentcorrection/6392323-6350342, http://linkedlifedata.com/resource/pubmed/commentcorrection/6392323-6365967, http://linkedlifedata.com/resource/pubmed/commentcorrection/6392323-6370567, http://linkedlifedata.com/resource/pubmed/commentcorrection/6392323-6371050, http://linkedlifedata.com/resource/pubmed/commentcorrection/6392323-6749890, http://linkedlifedata.com/resource/pubmed/commentcorrection/6392323-6764772, http://linkedlifedata.com/resource/pubmed/commentcorrection/6392323-6999019, http://linkedlifedata.com/resource/pubmed/commentcorrection/6392323-7014610, http://linkedlifedata.com/resource/pubmed/commentcorrection/6392323-7024299, http://linkedlifedata.com/resource/pubmed/commentcorrection/6392323-7040457, http://linkedlifedata.com/resource/pubmed/commentcorrection/6392323-7050148, http://linkedlifedata.com/resource/pubmed/commentcorrection/6392323-7050149
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0095-1137
pubmed:author
pubmed:issnType
Print
pubmed:volume
20
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
899-904
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1984
pubmed:articleTitle
Collaborative evaluation of the Abbott Avantage system for identification of frequently isolated nonfermentative or oxidase-positive gram-negative bacilli.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't